Morningstar Dækning af Danske Aktier

Morningstar har kvalitativ dækning af 9 danske aktier. Novo Nordisk og Novozymes er de eneste to danske aktier vi klassificerer som Wide Moat selskaber. Aktuelt er William Demant mest undervurderet i forhold til Morningstars fair value estimat, mens AP Møller Mærsk omvendt vurderes at være den mest overvurderede danske aktie.

Facebook Twitter LinkedIn

Se listen med danske aktier som Morningstars aktieanalytikere følger.

©2014 Morningstar. All rights reserved. The information, data, analyses, and opinions contained herein (1) are proprietary to Morningstar, Inc. and its affiliates (collectively, “Morningstar”), (2) may not be copied or redis­tributed, (3) do not constitute investment advice offered by Morningstar (4) are provided solely for informational purposes and therefore are not an offer to buy or sell a security, and (5) are not warranted to be accurate, complete, or timely. Certain information may be self-reported by the investment vehicle and not subject to independent verification. Morningstar shall not be responsible for any trading decisions, damages, or other losses resulting from, or related to, this information, data, analyses or opinions or their use. Past performance is no guarantee of future results.

Facebook Twitter LinkedIn

Om forfatteren

Morningstar Analysts   -

© Copyright 2024 Morningstar, Inc. All rights reserved.

Brugervilkår        Fortrolighedspolitik        Cookie Settings        Offentliggørelser